As a representative drug sequencing approach, T-DXd sequential therapy after T-DM1 showed a trend of superiority over RC48, and the efficacy benefit is not affected by the order in which they are applied.
← all excerpts
The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study.
1
—
—